ClinicalTrials.gg
CompletedNCT02050685Updated Jan 6, 2016

Comparison of Different Screening Score for Hypoxemic OSA (Obstructive Sleep Apnea) With the Results of a Polysomnography (PSG)

An observational study in Sleep Apnea, Obstructive, sponsored by Eric DEFLANDRE, MD, FCCP. Completed at 1 site in Belgium. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-01-06.

Sponsored by Eric DEFLANDRE, MD, FCCP · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
159
Ages
18 Years and older
Sex
All
01

Study summary

Comparison of different screening score for hypoxemic OSA (Obstructive Sleep Apnea) with the results of a polysomnography (PSG). The different screening score studied are: STOP-BANG, DES-OSA, P-SAP and OSA50.

Read the detailed description

The investigators should compare the four screening scores (STOP-BANG, DES-OSA, P-SAP and OSA50) with the results of the PSG (and in particular the number of apnea and hypopnea index and the probability of hypoxemia).

02

Conditions studied

  • Sleep Apnea, Obstructive
03

In context

Sleep Apnea, Obstructive

2,263 studies on the registry are indexed under Sleep Apnea, Obstructive; 465 are open to participants now.

This study's enrollment of 159 is above the median of 105 across 666 observational studies indexed under Sleep Apnea, Obstructive.

Browse Sleep Apnea, Obstructive studies →

Lead sponsor

This is the only study on the registry with Eric DEFLANDRE, MD, FCCP as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

All adults patients for an overnight polysomnography at SLBO.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults patients (> 18 years)

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
159 participants (actual)
Patient registry
No

Groups and cohorts

  • All patients for PSG at SLBO

    All patients incoming in the sleep study centre for a PSG. At the arrival the screening score will be recorder. AHI will be recorded next morning after analysis of the PSG.

    Other: All patients incoming in the sleep study centre for a PSG

Interventions

  • OtherAll patients incoming in the sleep study centre for a PSG

    All patients incoming in the sleep study centre for a PSG. Comparison between screening score and AHI derived from PSG.

06

What researchers measure

Primary outcomes

  1. Comparison of the DES-OSA score with previously described scores.

    Comparison of the DES-OSA score with the results of previously described scores (STOP-BANG, P-SAP and OSA50).

    Time frame: The day before the PSG (PolySomnoGraphy)

Secondary outcomes

  1. Comparison of the four screening scores with results of the PSG.

    Comparison of the four screening scores collected past day (before PSG - PolySomnoGraphy) with the results of the PSG (especially the AHI: Apnea Hypopnea Index)

    Time frame: The day after the polysomnography

07

Study locations

1 site
  • Clinique Saint-Luc de Bouge
    Bouge, Namur 5004, Belgium
08

References and documents

Publications

  • Deflandre E, Piette N, Bonhomme V, Degey S, Cambron L, Poirrier R, Brichant JF, Joris J. Comparison of clinical scores in their ability to detect hypoxemic severe OSA patients. PLoS One. 2018 May 7;13(5):e0196270. doi: 10.1371/journal.pone.0196270. eCollection 2018. PubMed 29734398 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2014, a primary completion of Dec 2015 and a completion of Dec 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 24, 2014
First posted
Jan 31, 2014
Start
Jan 2014
Primary completionActual
Dec 2015
CompletionActual
Dec 2015
Last update
Jan 6, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 6, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02050685
Lead sponsor
Eric DEFLANDRE, MD, FCCP
Responsible party
Eric DEFLANDRE, MD, FCCP (ERIC DEFLANDRE, MD, FCCP, Astes) — Sponsor-investigator
First posted
Jan 31, 2014
Start date
Jan 2014
Primary completion
Dec 2015
Completion
Dec 2015
Last update
Jan 6, 2016

Study contacts

Eric P DEFLANDRE, MD, FCCP
principal investigator · Astes

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion